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Abstract
Adenoviral vector (Ad)-mediated gene transfer is an attractive method for manipulating the immunostimulatory properties of dendritic cells
(DCs) for cancer immunotherapy. DCs treated with Ad have phenotype alterations (maturation) that facilitate T cell sensitization. We investigated
the mechanisms of DC maturation with Ad transduction. Expression levels of a maturation marker (CD40) on DCs treated with conventional Ad,
fiber-modified Ads (AdRGD, AdF35, AdF35ΔRGD), or a different serotype Ad (Ad35) were correlated with their transduction efficacy. The αv-
integrin directional Ad, AdRGD, exhibited the most potent ability to enhance both foreign gene expression and CD40 expression, and induced
secretion of interleukin-12, tumor necrosis factor-α, and interferon-α in DCs. The presence of a foreign gene expression cassette in AdRGD was
not necessary for DC maturation. Maturation of DCs treated with AdRGD was suppressed by destruction of the Ad genome, inhibition of
endocytosis, or endosome acidification, whereas proteasome inhibition increased CD40 expression levels on DCs. Moreover, inhibition of αv-
integrin signal transduction and blockade of cytokine secretion affected the maturation of DCs treated with AdRGD only slightly or not at all,
respectively. Thus, our data provide evidence that Ad-induced DC maturation is due to Ad invasion of the DCs, followed by nuclear transport of
the Ad genome, and not to the expression of foreign genes.
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Dendritic cells (DCs) are unique in their ability to sensitize
naive immune cells and to stimulate memory effector cells.
Recent advances in DC biology, tumor immunology, and
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doi:10.1016/j.virol.2007.12.043manipulate DCs ex vivo to induce effective anti-tumor immune
responses in cancer immunotherapy (Hsu et al., 1996; Nestle
et al., 1998). Genetic modification of DCs with specific se-
quences of tumor-associated antigen (TAA) genes offers major
advantages compared to other approaches. Following the
transduction of TAA genes into DCs, full-length TAA proteins
are expected to be physiologically processed and presented via
major histocompatibility complex (MHC) class I molecules by
DCs. Therefore, this is a method for activating specific anti-
tumor CD8+ cytotoxic T lymphocytes (CTLs) with the full
spectrum of antigenic determinants. Furthermore, TAA gene-
modified DCs also present MHC class II-restricted epitope(s) to
412 N. Kanagawa et al. / Virology 374 (2008) 411–420CD4+ T cells, and can express TAA continuously and MHC–
peptide complexes for long periods (Yang et al., 1998; Sloan
et al., 2002; Herrera et al., 2002).
Adenoviral vectors (Ads) were originally developed for gene
therapy because of their high in vitro and in vivo transduction and
expression efficacy in a broad range of cell types. Among variousFig. 1. Schematic representation of gene constructs (A) and tropism (B) of Ad varian
promoter; BGH P(A), bovine growth hormone polyadenylation signal.techniques for transferring the TAA gene to DCs, the ex vivo
engineering of DCs using Ad provides encouraging results (Wan
et al., 1999; Kaplan et al., 1999; Steitz et al., 2001). The gene
transduction efficiency of conventional Ad, which is based on the
adenovirus subgroup C serotype 5 backbone, against mouse and
human DCs is not sufficient, however, because DCs express littlets used in this study. ITR, inverted terminal repeat; CMV prom, cytomegalovirus
Fig. 1 (continued ).
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Ad receptor (Okada et al., 2001a,b, 2003a). We previously
reported that the RGD fiber-mutant Ad (AdRGD), which targets
αv-integrin upon attachment to cells by insertion of the RGD
peptide to the HI loop of the fiber knob, exhibited highly efficient
transduction compared to conventional Ads (Okada et al., 2001a,
b, 2003a). AdRGD is a useful vector system that not only transfers
the TAA gene (Okada et al., 2003b, 2006), but also confers a new
function to DCs (Okada et al., 2005a,b) to potently induce TAA-
specific CTLs and anti-tumor efficacy in DC-based cancer
immunotherapy. Our series of studies revealed that transduction
with conventional Ad or AdRGD induced DC phenotype
alterations (maturation), although the mechanism is unknown
(Okada et al., 2001a,b, 2003a,b, 2005a,b, 2006).The present study was aimed at elucidating the factors in-
volved in the mechanisms underlying Ad-induced DC matura-
tion using several Ad variants and inhibitors of the gene
transduction pathway.
Results
Relation between the transduction efficacy and DC maturation
level
We assessed the transduction efficacy and maturation level of
DCs transduced with Ad variants by flow cytometric analysis.
The gene constructs and tropism of Ad variants used in this study
are summarized in Fig. 1. The DC maturation level was
414 N. Kanagawa et al. / Virology 374 (2008) 411–420determined by the CD40 expression level, because the increase in
CD40 expression was remarkable as compared with the
upregulation of other costimulatory molecules such as CD80
and CD86 (data not shown). An enhanced green fluorescent
protein (EGFP) gene-carrying conventional Ad (Ad-EGFP),
AdRGD (AdRGD-EGFP), and chimeric type 5/35 fiber-contain-
ing Ad (AdF35-EGFP) increased EGFP expression on DCs in a
vector particle (VP)-dependent manner (Fig. 2 and Supplemen-
tary Fig. 1). Moreover, CD40 expression correlated with gene
expression efficacy, andAdRGD exhibited themost potent ability
for EGFP gene transduction and DCmaturation induction. On the
other hand, AdF35ΔRGD-EGFP, which has type 35 fiber and no
RGD motif in the penton base, and EGFP gene-carrying Ad type
35 (Ad35-EGFP), which differs from type 5 Ad in its mechanism
of cell entry, induced little EGFP expression and DC maturation,
indicating that type 35 Ad fiber recognizes CD46 (Gaggar et al.,
2003), in which mouse DCs are defective (Sakurai et al., 2006).
When DCs were transduced with the complex of Lipofectamine
2000 reagent (LF) and either AdF35ΔRGD-EGFP or Ad35-
EGFP, CD40 expression levels were slightly enhanced and had
improved transduction efficacy. Similarly, LF-combined Ad-
EGFP or AdF35-EGFP induced EGFP expression and DCFig. 2. EGFPgene transduction efficiency and the upregulation of CD40 expression inD
LF-Ad variant complexes, which were prepared by incubation of each Ad variant and L
cultivation, these transducedDCswere stained by indirect immunofluorescence with ant
were analyzed by flow cytometry. Data are expressed as the mean of three independenmaturation more efficiently than each alone. Gene transduction
efficacy and maturation level were decreased by AdRGD-EGFP
in combination with LF, suggesting that LF might induce steric
hindrance in the αv-integrin recognition by the RGD motif in the
fiber knob of AdRGD. These data indicated that the Ad entry into
DCs was a critical event for maturation.
We then evaluated the profiles of cytokine secretion in DCs
treated with AdRGD-EGFP, which most efficiently promoted
CD40 expression levels. Protein expression levels of inter-
leukin-12 p40 (IL-12p40), tumor necrosis factor-α (TNF-α),
and interferon-α (IFN-α) in DCs increased with time after
treatment with AdRGD, whereas IFN-α secretion was detected
only at 24 h after transduction (Fig. 3). This finding suggested
that the autocrine or paracrine effects of these cytokines were
not the initial trigger for DC maturation by AdRGD transfec-
tion, although they might contribute to promote maturation.
The effect of gene delivery into the nucleus and foreign gene
expression by invading AdRGDs on DC maturation
To elucidate the necessity of delivery of the Ad genome into
the nucleus and foreign gene expression by invading AdRGDsCs transfectedwithAd variants. DCswere transfectedwith eachAd variant alone or
F (20 μg/ml) for 20 min at room temperature, at the indicated VP/cell. After 24-h
i-CD40mAbs. Frequencies of EGFP gene-expressingDCs and CD40-positive DCs
t experiments. Dot plot data are shown in Supplementary Fig. 1.
Fig. 3. Cytokine secretion profile in DCs transfected with AdRGD-EGFP. DCs were transfected with AdRGD-EGFP at 2000 VP/cell, and then cultured for the
indicated time. Culture supernatants of mock DCs (open column) and transduced DCs (filled column) were harvested, and the concentrations of murine IL-12p40,
TNF-α, and IFN-α proteins were measured by enzyme-linked immunosorbent assay. The data are presented as mean±SD of three independent cultures. N.D., not
detectable.
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AdRGD-EGFP (UV/AdRGD-EGFP) in which the Ad genome
was destroyed. UV/AdRGD-EGFP maintained the ability to
enter into the DCs (Fig. 4A). Cy3-labeled UV/AdRGD-EGFP
bound to the DC plasma membrane 30 min after treatment, and
then invaded the cytoplasm and eventually reached the nucleus,
the same as Cy3-labeled AdRGD-EGFP. DCs treated with UV/
AdRGD-EGFP did not express EGFP and did not exhibitFig. 4. Maturation frequency of DCs treated with inactivated AdRGD-EGFP or Ad
AdRGD-EGFP at 2000 VP/cell for 30, 60, or 120 min. Cellular uptake and intracellu
microscope. Nuclei were stained with Hoechst 33342. Scale bar, 10 μm. (B); DCs w
AdRGD-EGFP at 2000 VP/cell. After 24-h cultivation, these transduced DCs were
EGFP-positive DCs (dotted column) and CD40-positive DCs (filled column) wer
independent cultures. Statistical analysis was performed using ANOVA, ⁎pb0.01, van increased frequency of CD40-positive DCs (Fig. 4B). On
the other hand, AdRGD-Null, which carries no foreign gene
expression cassette, induced DC maturation as well as AdRGD-
EGFP. Noninfective heat-inactivated AdRGD-EGFP (Heat/
AdRGD-EGFP), in which capsid proteins were denatured, did
not induce either EGFP expression or DC maturation. These
findings led us to conclude that DC maturation by AdRGD
transfection was related to Ad genome delivery into the nucleusRGD-Null. (A); DCs were treated with Cy3-conjugated AdRGD-EGFP or UV/
lar trafficking of Cy3-labeled virions in DCs were observed under a fluorescence
ere transfected with AdRGD-EGFP, AdRGD-Null, UV/AdRGD-EGFP, or Heat/
stained by indirect immunofluorescence with anti-CD40 mAbs. Frequencies of
e analyzed by flow cytometry. The data are presented as mean±SD of four
ersus % of CD40+ DCs treated with AdRGD-EGFP. N.D., not detectable.
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expression or capsid protein recognition in the DCs.
Effects of various Ad transduction pathway inhibitors on DC
maturation
We analyzed the effect of intracellular traffic of Ad particles
on DC maturation using various inhibitors. Because AdRGD
most efficiently induced DC maturation, we predicted that DC
maturation was involved in the signal transduction through αv-
integrin binding of the RGD motif on the Ad-penton base. We
investigated the level of DC maturation induced by AdRGD in
the presence of wortmannin (WM), a phosphoinositide-3-OH
kinase (PI3K) inhibitor that is activated by αv-integrin binding.
WM slightly reduced the frequency of EGFP-positive and
CD40-positive DCs treated with AdRGD-EGFP (Fig. 5). This
result indicated that the αv-integrin–RGD motif interaction was
slightly related to the upregulation of CD40 expression on the
DCs. AdRGD entry into the cells through the endocytosis
pathway is dependent on integrin. The transduction efficiencyFig. 5. Effect of various inhibitors on EGFP gene transduction efficiency and
CD40-positive frequency in DCs transfected with AdRGD-EGFP. DCs were
preincubated for 1 h with 100 nM wortmannin (WM), 20 μM cytochalasin
B (CB), 300 μM chloroquine (CQ), 10 μM lactacystin (LC), or 5 μg/ml
brefeldin A (BA), and then transfected with AdRGD-EGFP at 2000 VP/cell in
the presence of each inhibitor. After 24-h cultivation, these transduced DCs were
stained by indirect immunofluorescence with anti-CD40 mAbs. Frequencies of
EGFP-positive DCs (dotted column) and CD40-positive DCs (filled column)
were analyzed by flow cytometry. The data are presented as the mean±SD of
four independent cultures. Statistical analysis was performed using ANOVA,
⁎pb0.01, versus % EGFP+ DCs treated with AdRGD-EGFP without inhibitors,
and #pb0.01, versus % CD40+ DCs treated with AdRGD-EGFP without
inhibitors. N.D., not detectable. The numerical value in parentheses indicates
mean fluorescence intensity (MFI) of EGFP or CD40 expression.and maturation level of DCs treated with AdRGD-EGFP were
slightly decreased in the presence of cytochalasin B (CB), an
endocytosis inhibitor. DC maturation induced by AdRGD
required Ad particles to enter into cells, but signal transduction
followed by endocytosis activity contributed little to DC
maturation. Subsequently, we investigated the necessity of
endosome escape, which indicates the transition of Ad particles
into the cytoplasm, for induction of the DC maturation signal
using chloroquine (CQ), which inhibits the change of acidity in
the endosome. CQ clearly decreased the expression level of
both the foreign gene and CD40 on the DCs. Therefore, these
results indicated that DC maturation required Ad entry into the
cytoplasm and the delivery of the Ad genome into the nucleus.
Lactacystin (LC), a proteasome inhibitor, greatly enhanced the
EGFP and CD40 expression levels in DCs treated with AdRGD,
suggesting that LC might increase the number of Ad particles
and Ad genomes by inhibiting Ad degradation. This finding
supported the hypothesis that DC maturation is related to
increased delivery of the Ad genome to the nucleus. In addition,
the CD40 and EGFP expression levels of DCs treated with
AdRGD in the presence of brefeldin A (BA), which blocks
cytokine secretion from DCs, were slightly higher than those of
AdRGD-transduced DCs without inhibitors. We again con-
firmed that cytokine (i.e., IL-12, TNF-α, and IFN-α) secretion
from the DCs did not act as the initial trigger for DC maturation.
Together, these results demonstrated that DC maturation
induced by AdRGD required AdRGD entry into the cytoplasm
through endocytosis, and that the trigger for DC maturation
functioned after AdRGD escaped the endosome.
Discussion
In Ad-mediated gene transduction, Ad first attaches to the
cell through an interaction between the carboxy terminus of the
fiber knob of the Ad particle and a cell surface receptor, known
as the CAR (Bergelson et al., 1997; Roelvink et al., 1998,
1999). Following the high-affinity binding to CAR, a lower-
affinity interaction between αvβ3- or αvβ5-integrins and the
RGD motif in the Ad-penton base facilitates internalization of
the virion by receptor-mediated endocytosis (Wickham et al.,
1993, 1994; Mathias et al., 1994). After internalization, Ad
penetrates the cytoplasm, which involves an acid-dependent
conformational change in the Ad-penton base (Wang et al.,
2000), and the recombinant viral DNA is delivered to the
nucleus. We and others previously reported that Ad transduction
induces DC maturation (Okada et al., 2001a, 2003a; Hirscho-
witz et al., 2000; Morelli et al., 2000; Rea et al., 1999; Philpott
et al., 2004; Liu et al., 2003; Molinier-Frenkel et al., 2003),
although the details of the mechanism were unknown. In the
present study, we attempted to elucidate the factors involved in
Ad-mediated DC maturation by examining the Ad transduction
pathway.
We first determined that the gene transduction efficiency of
Ad variants closely correlated with DC maturation levels, and
that AdRGD was the most efficient vector for DC maturation
among five Ad variants. In addition, our results using LF-Ad
variant complexes indicated that DC maturation required
417N. Kanagawa et al. / Virology 374 (2008) 411–420foreign gene expression based on the entry of Ad particles into
the cells, regardless of receptor-dependent or -independent
endocytosis. On the other hand, heat-inactive AdRGD did not
induce DC maturation as well as noninfective Ad treated with
sonication or surfactant (data not shown), suggesting that
pulsation of the Ad capsid proteins was not related to DC
maturation. Although several groups have argued that DC
maturation is mediated by Ad component proteins, e.g., the
penton base or fiber knob domain (Liu et al., 2003; Molinier-
Frenkel et al., 2003), our data agreed with the report that DC
maturation is independent of fiber content (Schoggins et al.,
2005).
The necessity of AdRGD particle entry via endocytosis for
DC maturation was also supported by an experiment using an
endocytosis inhibitor. Thus, we examined the relationship
between an endocytosis signal and DC maturation. The inter-
action between the RGD motif and αv-integrins, an endocytosis
receptor, induces the activation of PI3K (Li et al., 1998;
Nemerow, 2000). Previous reports showed that the nuclear
factor-κB signal mediated by the integrin–PI3K pathway
induces DC maturation through TNF-α production (Philpott
et al., 2004). Our result from an experiment using a PI3K
inhibitor, however, indicated that the αv-integrin–PI3K pathway
was not mainly, but rather only partially, involved in DC
maturation induced by AdRGD transduction. Moreover, our
collaborators confirmed that the toll-like receptor 9, which
recognizes microbial invasion in endosomes, and its adaptor
molecule (MyD88) do not contribute to Ad-mediated DC
maturation (Yamaguchi et al., 2007).
Additionally, AdRGD-mediated DC maturation was asso-
ciated with endosome escape by the AdRGD particles, and a
proteasome inhibitor promoted both foreign gene expression
and DC maturation. These results strongly suggest that DC
maturation levels reflect the amount and stability of the AdRGD
particles in the cytoplasm that delivered the recombinant viral
genome into the nucleus. Moreover, DC maturation levels were
equal between AdRGD-EGFP- and AdRGD-Null-treated DCs,
indicating that AdRGD induction of DC maturation was not
influenced by the presence of the foreign gene expression
cassette. This idea is supported by previous reports demonstrat-
ing that Ad-mediated DC maturation is independent of gene
expression (Hirschowitz et al., 2000; Morelli et al., 2000; Rea
et al., 1999). On the other hand, even if AdRGD particles were
able to enter into the DCs, destruction of the viral genome by
UV irradiation (Mulders et al., 1998) did not induce DC matu-
ration. Therefore, we concluded that delivery of the recombi-
nant viral genome into the nucleus, but not foreign gene
expression, was essential for DC maturation.
Although DCs transduced with AdRGD secreted inflamma-
tory cytokines such as IL-12, TNF-α, and IFN-α, blocking
cytokine secretion did not reduce the DC maturation levels. This
result was consistent with a previous report indicating that Ad
entry, but not the secretion of TNF-α or IFN-α through the
nuclear factor-κB pathway, triggered the DC maturation (Seiler
et al., 2007). We do not think that the autocrine and paracrine
effects of these cytokines triggered DC maturation in AdRGD
transduction, but speculate that they might at least contribute topromote and maintain the DC maturation status (Hensley et al.,
2005).
In conclusion, our data provide evidence that DC maturation
with Ad-mediated transduction results from the delivery of the
Ad genome into the nucleus. Our results also suggest that the
nucleus has certain molecular mechanisms for recognizing the
Ad genome. A recent report suggests that recognition of the Ad
particles occurs chiefly via a toll-like receptor-independent
nucleic acid-sensing mechanism that recognizes the viral
dsDNA genome, and that delivery of the viral genome triggers
IFN regulatory factor 3 phosphorylation (Nociari et al., 2007).
Further studies to analyze more detailed events in the nucleus
will allow us to better understand the factors that contribute to
the efficiency and safety of Ad gene therapy and DC-based
immunotherapy.
Materials and methods
Mice
Female C57BL/6 mice (H-2b), 8 to 12 weeks of age, were
purchased from Japan SLC Inc. (Hamamatsu, Japan), and were
maintained under specific pathogen-free conditions. Animals
were handled in accordance with the Osaka University and
Kyoto Pharmaceutical University guidelines for the welfare of
experimental animals.
Vectors
Ad-EGFP (Okada et al., 2001b), AdRGD-EGFP (Okada et al.,
2001b), and AdF35-EGFP (Mizuguchi and Hayakawa, 2002;
Sakurai et al., 2003) were previously constructed by an improved
in vitro ligation method (Mizuguchi and Kay, 1998, 1999).
AdRGD-Null, which is identical to AdRGD but without the gene
expression cassette, was previously constructed (Okada et al.,
2004). AdF35ΔRGD-EGFP was constructed using the vector
plasmid pAdHM35 as follows. pAd22 (Mizuguchi et al., 2002),
which has the Pme I–Asc I fragment of the adenovirus genome
(bp 13255–15672), was digested with Asc I and Hinc II and
ligated with Asc I/Hinc II-digested pHM5.1, which is a derivative
of pHM5 (Mizuguchi and Kay, 1999), resulting in pAd23, which
contains the Hinc II–Asc I fragment of the Ad genome (bp
14383–15672). pAd23 was then digested with Hinc II and Eag I
and ligated with Hinc II/Eag I-digested pAd25Δ (Mizuguchi
et al., 2002), which contains the Hinc II–Eag I fragment of the
Ad genome (bp 14383–15229) with a change in the Sac II–BssH
II fragment (bp 15133–15209) into oligonucleotide 4 (5′-
GGCAATGCAGCCGGTGGAGGACATGAACGATA-
CATCTAGAGCTGAGGAGAAG-3′) and oligonucleotide 5
(5′-CGCCGTTACGTCGGCCACCTCCTGTACTTGCTATG-
TAGATCTCGACTCCTCTTCGCGC) (theXba I site is underlined
and the RGD peptide motif of the penton base, MNDHAIRGDT-
FATRAE, was changed to MNDTSRE), resulting in pAd26Δ.
The altered sequence containing the penton base was then
introduced into pAdHM34 (Mizuguchi and Hayakawa, 2002) by
continuous routine plasmid construction using in vitro ligation.
The resulting vector plasmid pAdHM35 had a complete E1/E3-
418 N. Kanagawa et al. / Virology 374 (2008) 411–420deleted Ad genome with I-Ceu I, Swa I, and PI-Sce I sites in
the E1 deletion region, chimeric type 5/35 fiber sequence, and
the deletion of the RGD peptide motif of the penton base. The
EGFP expression cassette was inserted in the E1 deletion re-
gion by an improved in vitro ligation method, resulting in
AdF35ΔRGD-EGFP. Ad35-EGFP, which was based on the
adenovirus serotype 35 backbone with deletion of the E1 re-
gion, was generated as previously described (Sakurai et al., 2003).
All recombinant vectors were propagated, purified by two rounds
of cesium chloride gradient ultracentrifugation, dialyzed, and
stored at −80°C. Vector particle (VP) titers were evaluated
spectrophotometrically using the method of Maizel et al. (1968).
Gene constructs and tropism of Ad variants are summarized
in Fig. 1.
Generation of mouse bone marrow-derived DCs
DCs were prepared according to the method of Lutz et al.
(1999) with a slight modification. Briefly, bone marrow cells
flushed from the femurs and tibias of C57BL/6 mice were
seeded at 5×106 cells per sterile 100-mm bacterial grade culture
dish in 10 ml of RPMI 1640 medium containing 10% fetal
bovine serum, 40 ng/ml recombinant murine granulocyte/
macrophage colony-stimulating factor (GM-CSF; kindly pro-
vided by KIRIN Brewery Co., LTD., Tokyo, Japan), 50 μM 2-
mercaptoethanol, and antibiotics. On day 3, another 10 ml of the
culture medium was added to the dish for medium replenish-
ment. On day 6, 10 ml of the culture supernatant was collected
and centrifuged at 1500 rpm for 5 min at room temperature, and
the pellet was resuspended in 10 ml of fresh culture medium,
and then returned to the original dish to conserve unattached
cells. Eight-day old DCs (non-adherent cells) were harvested
and used as intact immature DCs in subsequent experiments.
Viral transduction into DCs
DCs were suspended at a concentration of 5×106 cells/ml in
fetal bovine serum-free RPMI 1640 medium and placed in a 50-
ml conical tube. Each Ad variant was added at various VP/cell,
the suspension was mixed well, and the tube was incubated at
37 °C for 2 h with occasional gentle agitation. In some cases,
DCs were transfected with vector–cationic lipid complexes that
were prepared by incubation of each Ad variant and 20 μg/ml
LF (Invitrogen, Carlsbad, CA) at room temperature for 20 min.
The cells were washed three times with phosphate-buffered
saline (PBS) and resuspended in a suitable solution.
Analysis of EGFP gene transduction efficiency and CD40
expression levels in transduced DCs
The frequencies of EGFP-positive and CD40-positive
transduced DCs cultured in GM-CSF-free medium for 24 h
post-transfection were assessed by flow cytometric analysis.
Briefly, 106 cells in 100 μl staining buffer (PBS containing
0.1% bovine serum albumin and 0.01% NaN3) were incubated
for 30 min on ice with the anti-FcγRII/III monoclonal antibody
(mAb; clone 2.4G2) to block nonspecific binding of thesubsequently used immunoreagents. The cells were incubated
for 30 min on ice using the manufacturer's recommended
amounts of biotinylated anti-CD40 mAb (clone GL1). The cells
were then resuspended in 100 μl staining buffer containing
PerCP-conjugated streptavidin at a 1:200 dilution, and non-
specific binding was measured using PerCP-conjugated strep-
tavidin alone. After incubation for 30 min on ice, EGFP gene
transduction efficiency and the CD40 expression levels in the
transduced DCs were analyzed by flow cytometry on a
FACSCalibur flow cytometer using CellQuest software (Becton
Dickinson, Tokyo, Japan), acquiring 30,000 events by forward
and side scatter gating to exclude cell debris. Between all
incubation steps, cells were washed three times with staining
buffer. All immunoreagents used in the present study were
purchased from BD Bioscience (San Jose, CA).
Analysis of cytokine production in transduced DCs
DCs transduced with AdRGD-EGFP at 2000 VP/cell and
mock DCs were cultured in GM-CSF-free culture medium for 3,
6, 12, or 24 h. The culture supernatants were collected, and the
IL-12p40, TNF-α, and IFN-α concentrations were measured
with the corresponding enzyme-linked immunosorbent assay
kits (Biosource International, Camarillo, CA).
Preparation of inactivated AdRGD-EGFP
UV-irradiated AdRGD-EGFP (UV/AdRGD-EGFP) was
prepared according to the methods reported by Kodama et al.
(2001) and Cotton et al. (1992). Heat/AdRGD-EGFP was
prepared by incubation in a hot bath for 5 min.
Analysis of cellular uptake and intracellular trafficking of UV/
AdRGD-EGFP in DCs
AdRGD-EGFP and UV/AdRGD-EGFP were labeled by Cy3
(Amersham Pharmacia Biotech, Tokyo, Japan) according to the
method of Miyazawa et al. (1999). The Cy3-labeling efficiency,
the ratio of Cy3-fluorescence intensity to the number of virions,
was equal for both vectors (data not shown). Cy3-labeled
AdRGD-EGFP or UV/AdRGD-EGFP was added to cultured
DCs at 2000 VP/cell. After 30, 60, or 120 min, DCs were
repeatedly washed with PBS and treated with Hoechst 33342
(Dojindo Laboratories, Kumamoto, Japan) for nuclear staining.
Cellular uptake and intracellular trafficking of Cy3-labeled
virions were observed under a fluorescence microscope (BZ-
8000; Keyence Corporation, Osaka, Japan).
Treatment with various inhibitors in the transfection procedure
DCs were preincubated with 100 nM WM (Sigma Chemical
Co., St. Louis, MO), 20 μMCB (Sigma Chemical Co.), 300 μM
CQ (Sigma Chemical Co.), 10 μM LC (BIOMOL Research
Laboratories, Inc., Plymouth Meeting, PA), or 5 μg/ml BA
(Sigma Chemical Co.) for 1 h, and then transfected with
AdRGD-EGFP at 2000 VP/cell in the presence of each in-
hibitor. We confirmed that the inhibitors had no effect on cell
419N. Kanagawa et al. / Virology 374 (2008) 411–420viability at the concentrations used in this experiment (data not
shown).
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